Article Information
History
- September 17, 2022.
Article Versions
- You are currently viewing Version 1 of this article (September 17, 2022 - 10:28).
- Version 2 (September 21, 2022 - 07:01).
- Version 3 (January 27, 2023 - 14:00).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Brian Sullivana,*,
- Edward Barkera,
- Philip Williamsc,
- Louis MacGregora,
- Ranjeet Bhambera,
- Matt Thomasb,
- Stefan Gurneyc,
- Catherine Hyamsa,b,
- Alastair Whitewayb,
- Jennifer A Coopera,
- Chris McWilliamsa,
- Katy Turnera,
- Andrew W. Dowseya and
- Mahableshwar Alburb,*
- aUniversity Of Bristol
- bSouthmead Hospital, North Bristol NHS Trust
- cUniversity Hospitals Bristol and Weston NHS Trust
- ↵*Corresponding Authors Email addresses: brian.sullivan{at}bristol.ac.uk (Brian Sullivan), mahableshwar.albur{at}nbt.nhs.uk (Mahableshwar Albur)
Posted September 17, 2022.
Bayesian Prediction of Severe Outcomes in the LabMarCS: Laboratory Markers of COVID-19 Severity - Bristol Cohort
